Biomics Biotechnologies Co., Ltd.
Records under this name other than patents Biomics Biotechnologies Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 10 of 10 · Back to Biomics Biotechnologies Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,820,942 | Lipidosome preparation, preparation method and application thereof Lapsed on the fee record Ended Nov 21, 2025 · USPTO record | Lapsed on the fee record | Ended Nov 21, 2025 | USPTO record |
| US 8,563,710 | Modified oligonucleotide and its preparation and application Lapsed on the fee record Ended Oct 22, 2025 · USPTO record | Lapsed on the fee record | Ended Oct 22, 2025 | USPTO record |
| US 9,777,278 | Long interfering nucleic acid duplexes targeting multiple RNA targets Lapsed on the fee record Ended Oct 3, 2025 · USPTO record | Lapsed on the fee record | Ended Oct 3, 2025 | USPTO record |
| US 8,217,163 | Application of highly conserved domain sequences from viral genome as template to design therapeutic slirnas Formerly held Lapsed on the fee record Ended Jul 10, 2024 · USPTO record | Lapsed on the fee record | Ended Jul 10, 2024 | USPTO record |
| US 9,284,560 | Application of highly conserved domain sequences from viral genome as template to design therapeutic sliRNAs Lapsed on the fee record Ended Mar 15, 2024 · USPTO record | Lapsed on the fee record | Ended Mar 15, 2024 | USPTO record |
| US 10,443,057 | Multi-targets interfering RNA molecules and their applications Lapsed on the fee record Ended Oct 15, 2023 · USPTO record | Lapsed on the fee record | Ended Oct 15, 2023 | USPTO record |
| US 9,115,167 | Multi-targets interfering RNA molecules and their applications Lapsed on the fee record Ended Aug 25, 2023 · USPTO record | Lapsed on the fee record | Ended Aug 25, 2023 | USPTO record |
| US 9,080,174 | HBV Treatment Formerly held Lapsed on the fee record Ended Jul 14, 2023 · High confidence | Lapsed on the fee record | Ended Jul 14, 2023 | High confidence |
| US 8,846,895 | Double-stranded RNA molecules with stability in mammalian body fluid, preparation and application thereof Lapsed on the fee record Ended Sep 30, 2022 · USPTO record | Lapsed on the fee record | Ended Sep 30, 2022 | USPTO record |
| US 9,944,928 | Construction of pool of interfering nucleic acids covering entire RNA target sequence and related compositions Lapsed on the fee record Ended Apr 17, 2022 · USPTO record | Lapsed on the fee record | Ended Apr 17, 2022 | USPTO record |